1. Predictive value of combining urinary N-acetyl-β-D-glucosaminidase and serum homocysteine for contrast-induced nephropathy in patients after percutaneous coronary intervention
- Author
-
Yiling Zhai, Changjun Luo, Nianying Qin, Hongying Cao, Chunyang Dong, Zhou Huang, Dongling Huang, Fan Wang, Wanxia Wei, Jincheng Li, Jie Yang, Xueling Lu, Zhengzhuang Huang, and Wei Wang
- Subjects
N-acetyl-β-D-glucosaminidase ,homocysteine ,biomarker ,percutaneous coronary intervention ,contrast-induced nephropathy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundContrast-induced nephropathy (CIN) can lead to serious complications following percutaneous coronary intervention (PCI). Urine N-Acetyl-β-D-glucosaminidase (uNAG) and serum homocysteine (sHCY) are both potential predictors for CIN detection, but their combination has not been explored. We aimed to combine uNAG and sHCY as predictors for the early detection of CIN and for prognosis prediction in patients after PCI.MethodsA total of 232 consecutive patients who underwent PCI at a university hospital were recruited for this study. According to the European Society of Urology and Reproduction (ESUR) criterion, CIN is defined as an elevation of serum creatinine (sCr) by ≥25% or ≥0.5 mg/dl from baseline within 48 h. We assessed the use of individual biomarkers (uNAG and sHCY) measured around PCI and their combinations for CIN detection and prognosis prediction. Receiver operating characteristic curves (ROC) and area under the curve (AUC) were used to evaluate the predictive efficiency of potential predictors.ResultsIn total, 54 (23.28%) patients developed CIN. Concentrations of uNAG and sHCY increased significantly in CIN subjects (p
- Published
- 2024
- Full Text
- View/download PDF